These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28826564)

  • 41. Prevalence of familial hypercholesterolaemia in patients presenting with premature acute coronary syndrome.
    Hauguel-Moreau M; Aïdan V; Hergault H; Beauchet A; Pépin M; Prati G; Pillière R; Ouadahi M; Josseran L; Rodon C; Rabès JP; Charron P; Dubourg O; Massy Z; Mansencal N
    Arch Cardiovasc Dis; 2022 Feb; 115(2):87-95. PubMed ID: 35123917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A
    J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lipoprotein(a) in heterozygote familial hypercholesterolemia].
    Ochoa Sosa CA; Zamora González J; González Hermosillo JA; Ize Lema I; Cardoso Saldaña G; Posadas Romero C
    Arch Inst Cardiol Mex; 1994; 64(6):549-55. PubMed ID: 7726691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
    Hu P; Dharmayat KI; Stevens CAT; Sharabiani MTA; Jones RS; Watts GF; Genest J; Ray KK; Vallejo-Vaz AJ
    Circulation; 2020 Jun; 141(22):1742-1759. PubMed ID: 32468833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
    J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Low-Density Lipoprotein Cholesterol With Risk of Aortic Valve Stenosis in Familial Hypercholesterolemia.
    Mundal LJ; Hovland A; Igland J; Veierød MB; Holven KB; Bogsrud MP; Tell GS; Leren TP; Retterstøl K
    JAMA Cardiol; 2019 Nov; 4(11):1156-1159. PubMed ID: 31617858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
    Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
    J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Robinson JG
    J Manag Care Pharm; 2013 Mar; 19(2):139-49. PubMed ID: 23461430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prevalence of familial hypercholesterolemia in the West Siberian region of the Russian Federation: A substudy of the ESSE-RF.
    Ershova AI; Meshkov AN; Bazhan SS; Storozhok MA; Efanov AY; Medvedeva IV; Indukaeva EV; Danilchenko YV; Kuzmina OK; Barbarash OL; Deev AD; Shalnova SA; Boytsov SA
    PLoS One; 2017; 12(7):e0181148. PubMed ID: 28719663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.
    Junyent M; Gilabert R; Jarauta E; Núñez I; Cofán M; Civeira F; Pocoví M; Mallén M; Zambón D; Almagro F; Vega J; Tejedor D; Ros E
    Atherosclerosis; 2010 Feb; 208(2):437-41. PubMed ID: 19717150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.
    Al-Rasadi K; Alhabib KF; Al-Allaf F; Al-Waili K; Al-Zakwani I; AlSarraf A; Almahmeed W; AlSayed N; Alghamdi M; Batais MA; Almigbal TH; Alnouri F; Kinsara A; Hammouda A; Awan Z; Kary H; Elamin OA; Zadjali F; Al-Jarallah M; Shehab A; Sabbour H; Amin H; Altaradi H
    Curr Vasc Pharmacol; 2020; 18(1):57-64. PubMed ID: 30289081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
    Beheshti SO; Madsen CM; Varbo A; Nordestgaard BG
    J Am Coll Cardiol; 2020 May; 75(20):2553-2566. PubMed ID: 32439005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Ohmura H; Fukushima Y; Mizuno A; Niwa K; Kobayashi Y; Ebina T; Kimura K; Ishibashi S; Daida H;
    Int Heart J; 2017 Feb; 58(1):88-94. PubMed ID: 28123161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
    Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
    J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Women with familial hypercholesterolemia phenotype are undertreated and poorly controlled compared to men.
    Zamora A; Ramos R; Comas-Cufi M; García-Gil M; Martí-Lluch R; Plana N; Alves-Cabratosa L; Ponjoan A; Rodríguez-Borjabad C; Ibarretxe D; Roman-Degano I; Marrugat J; Elosua R; Martín-Urda A; Masana L
    Sci Rep; 2023 Jan; 13(1):1492. PubMed ID: 36707646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
    Sinan ÜY; Sansoy V
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit.
    Pang J; Poulter EB; Bell DA; Bates TR; Jefferson VL; Hillis GS; Schultz CJ; Watts GF
    J Clin Lipidol; 2015; 9(5):703-8. PubMed ID: 26350818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.